Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135668 · ClinicalTrials.gov registry record · Phase 2
Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room
A Phase 2 study, sponsored by The Emmes Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 211
- Enrollment target
NCT00135668 is a Phase 2 study that has completed, run by The Emmes Company. The registered enrollment target is 211 participants.
The verdict
NCT00135668, a Phase 2 study, has completed, sponsored by The Emmes Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 211 participants
- Enrollment target
Study Summary
Sodium nitroprusside (SNP) has been approved for control of blood pressure in adults, yet there are no controlled studies in children. The purpose of this study is to determine the efficacy and safety of sodium nitroprusside in children who will be having surgery, and who require blood pressure lowering in order to decrease the amount of blood loss during their surgery.
Interventions
- DRUG Nitroprusside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00135668
The ClinicalTrials.gov registry entry for NCT00135668 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Emmes Company, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitroprusside is the first listed.
NCT00135668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00135668 about?
NCT00135668 is a clinical study titled "Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room". Sodium nitroprusside (SNP) has been approved for control of blood pressure in adults, yet there are no controlled studies in children. The purpose of this study is to determine the efficacy and safety of sodium nitroprusside in children who will be having surgery, and who require blood pressure lowe...
What is the current status of trial NCT00135668?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 211 participants. The study started on 2005-08. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00135668?
The interventions under investigation include: Nitroprusside (DRUG).
Who is sponsoring clinical trial NCT00135668?
This trial is sponsored by The Emmes Company, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.